Efficacy of DAAs in the Treatment of Chronic HCV: Real-World Data from the Private Health-Care Sector of the Kingdom of Saudi Arabia
Background and Aim: The hepatitis C virus (HCV) is considered a global health challenge that requires urgent interventions for prevention and control. In this study, we aimed to evaluate the effectiveness of direct-acting antiviral agents (DAAs) for HCV-infected patients in the Kingdom of Saudi Arab...
Main Authors: | Almoutaz Hashim, Fadia Almahdi, Emad Aldin Albaba, Ohoud Barkia, Reem Alkasam, Asmaa Almahmoud, Ahmed Nabil, Ayman Alsulaimani, Mahmoud Mosli |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2020-02-01
|
Series: | Journal of Epidemiology and Global Health |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125934715/view |
Similar Items
-
The Management of Anemia in Patients with HCV Treated with DAA
by: Stavar Angelica Nela, et al.
Published: (2017-05-01) -
Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019-12-01) -
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
by: Nicolò de Gennaro, et al.
Published: (2020-03-01) -
Treatment and re-treatment results of HCV patients in the DAA era.
by: Felix Piecha, et al.
Published: (2020-01-01) -
WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS
by: Giovanni Faria SILVA, et al.